E
Cytek Biosciences, Inc. CTKB
$4.14 -$0.03-0.72% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -6.40M -11.25M -6.02M -10.16M -17.56M
Total Depreciation and Amortization 11.42M 10.91M 10.49M 10.17M 9.92M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.18M 12.74M 13.20M 23.51M 22.22M
Change in Net Operating Assets 3.00K 8.90M 7.71M 9.37M 846.00K
Cash from Operations 15.20M 21.30M 25.38M 32.89M 15.43M
Capital Expenditure -4.33M -3.81M -3.53M -4.13M -4.45M
Sale of Property, Plant, and Equipment 268.00K 321.00K 288.00K 97.00K 76.00K
Cash Acquisitions -471.00K -471.00K -471.00K -236.00K -237.00K
Divestitures -- -- -- -- --
Other Investing Activities -81.67M -63.81M -79.27M 13.80M 73.07M
Cash from Investing -86.20M -67.77M -82.97M 9.53M 68.46M
Total Debt Issued 4.87M 3.48M 4.18M 1.40M 1.39M
Total Debt Repaid -1.94M -1.94M -557.00K -558.00K -556.00K
Issuance of Common Stock 1.79M 2.25M 2.72M 3.11M 3.41M
Repurchase of Common Stock -34.59M -32.77M -22.17M -49.89M -46.37M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -29.87M -28.98M -15.82M -45.94M -42.13M
Foreign Exchange rate Adjustments -1.57M 1.61M 4.53M 2.19M 4.61M
Miscellaneous Cash Flow Adjustments -1.00K -- -- -- --
Net Change in Cash -102.45M -73.84M -68.89M -1.33M 46.37M